Neoplasia/BPH

	Effect of mind map-guided nursing on pain control after transurethral resection of the prostate. Braz J Med Biol Res Zhao N, Tian E. PMID: 42018813 [PubMed - indexed for MEDLINE]
	Prognostic Value of PALBI in Patients With Hepatocellular Carcinoma and Concurrent Chronic Kidney Disease: A Nomogram Development. Hepatol Res Lim J, Kim SH, Song MJ. PMID: 42018764 [PubMed - as supplied by publisher]
	Diagnostic Approaches to Adult Cystic Nephroma: Insights From Two Cases. Am J Case Rep Bosoteanu M, Vod, Or, Nurla LA, Ciufu N. PMID: 42018497 [PubMed - indexed for MEDLINE]
	TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies. Mol Cancer Ther Hoshi-Kadonosawa Y, Reinhold WC, Taniyama D, Inoue Y, Luna A, Kumar S, Sun NY, Kim YS, Yin JJ, Roper N, Sowalsky AG, Figg WD, Takebe N, Pommier Y. PMID: 42018155 [PubMed - as supplied by publisher]
	CD39/CD73-mediated immunosuppression and tumor aggressiveness in bladder cancer. Cancer Immunol Immunother Furriel F, Laranjeira P, Pereira M, Silva S, Silva I, Fontinha G, Sousa V, Gomes C, Parada B, Paiva A. PMID: 42018002 [PubMed - indexed for MEDLINE]
	Clinical Benefit and Safety of Combined Immunotherapy and Targeted Therapy in Prostate Cancer. Int J Cancer Han Z, Yi X, Tang Y, Li X, Liao D, Xu H, Zheng X, Ai J. PMID: 42017392 [PubMed - as supplied by publisher]
	Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing. NAR Cancer Cuevas-Estrada B, Ríos-Rodríguez JA, García-Pacheco JA, Wegman-Ostrosky T, Cervera A, Alcaraz N, Montalvo-Casimiro M, Barrón-Hernández A, Castro-Hernández C, Jiménez-Ríos MA, Sobrevilla-Moreno N, Arriaga-Canon C, Herrera LA, González-Barrios R. PMID: 42017013 [PubMed - indexed for MEDLINE]
	PSMA-Targeting Macrophage Membrane-Coated Nanoparticles for Precision Diagnosis and Combination Therapy of Prostate Cancer. Exploration (Beijing) Zhang K, Gao B, Wang J, Li Y, Xu C, Yang F, Liu S, Li H, Zhang C, Meng X, Shi Z, Zhang R, Zhang R, Wang Z, Wen W, Zhang Q, Zou Y, Han D, Bian H, Qin W. PMID: 42016765 [PubMed]
	Predicting recurrence of prostate cancer after radical treatment using AI models based on PET/CT radiomics: a dual-center study. Front Oncol Yi Z, Li W, Lou Y, Zhou Q. PMID: 42016705 [PubMed]
	Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study. Int J Urol Ye D, Saad M, Lee JY, Jung W, Pang ST, Li L, Gurney H, Attard G, Chi KN, Mundle S, Zhuo J, Singh A, Lin Y, Sandhu S. PMID: 42015879 [PubMed - indexed for MEDLINE]
	Evaluating the Impact of Age on Prostate Cancer Overdiagnosis Using Long-Term Follow-Up From the CAP Randomised Trial. Int J Cancer Brentnall AR, Rebolj M, Sasieni P, Funston G, Gabe R, Vickers AJ. PMID: 42015666 [PubMed - as supplied by publisher]
	Ultrasound Diagnosis of Giant Testicular Adrenal Residual Tumors: A Case Report and Literature Review. J Clin Ultrasound Ge Y, Zhu H, Kong D, Wang Y, Mao L. PMID: 42015359 [PubMed - as supplied by publisher]
	Standardized Program of Resistance Training for Prostate Cancer Patients Receiving Androgen Deprivation Therapy (SPoRT-PCa-ADT): study protocol for a randomized controlled trial. BMC Cancer Soler-López A, Gómez-Carmona CD, González-Devesa D, López-Plaza D, Herrero-Vidal L, Toledo-Pozuelo R, González-Costea A, Cao-Avellaneda E. PMID: 42015017 [PubMed - as supplied by publisher]
	Prognostic impact of large cribriform architecture and intraductal carcinoma of the prostate in diagnostic biopsies of mCSPC receiving ARPI-based therapy. Jpn J Clin Oncol Sato S, Urabe F, Imai Y, Iwamoto Y, Iwatani K, Tashiro K, Tsuzuki S, Umemori M, Miki J, Kimura T, Shimoda M, Takahashi H. PMID: 42014352 [PubMed - as supplied by publisher]
	ProHealth: a co-designed online home-based healthy eating and exercise programme for men with prostate cancer treated with androgen deprivation therapy - a study protocol for a feasibility and preliminary efficacy randomised controlled trial. BMJ Open Baguley B, Daly R, Livingston P, Rawstorn J, White V, Koorts H, Fraser S, Gardner J, Atkins L, Steer B, O E, Heneka N, Abbott G, Russell G, McNamara G, Kiss N. PMID: 42014146 [PubMed - indexed for MEDLINE]
	Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial. Cell Rep Med Liu Y, Zhang XY, Wei WS, Liu RQ, Pan QW, Zhang YJ, Li JB, Peng YL, Huang TX, Zhang ZL, Han H, Guo SJ, Gao JM, Zhou FJ, Dong P, He LR. PMID: 42013852 [PubMed - as supplied by publisher]
	Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy. Cancer Control Aksoy RA, Koca T, Çetmi DA, K, Korcum AF. PMID: 42013016 [PubMed - indexed for MEDLINE]
	Prostate Cancer Incidence, Mortality, and Survival in Switzerland. JAMA Netw Open Menges D, Wildisen L, Scherer T, Tancredi S, Würnschimmel C, Sigg S, Hao S, Lippuner M, Cathomas R, Templeton AJ, Chmiel C, Rentsch CA, Eberli D, Kwiatkowski M, Mortezavi A, Chiolero A, Rohrmann S, Clements M, Staehelin K. PMID: 42012828 [PubMed - indexed for MEDLINE]
	Streamlined calculation of kidney function using dynamic contrast-enhanced MRI with population-based arterial input function and a whole-kidney model. Eur Radiol Exp Mu X, Liu MM, Al-Mubarak H, Kennedy P, Robson P, Cuevas J, Kuhn B, Badani K, Taouli B, Lewis S, Bane O. PMID: 42012724 [PubMed - indexed for MEDLINE]
	Habitat-based radiomics-clinical analysis for early prediction of bladder cancer recurrence: a retrospective cohort study. Abdom Radiol (NY) Yang Y, Gong B, Kong X, Guo Y, Lou J, Fu X, Liu W, Feng Q, Yang L. PMID: 42012493 [PubMed - as supplied by publisher]

Articles 1 - 20 / 187225

Page 1 of 9362



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy